Clinical Trial Update: Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill Infants [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of mupirocin to eradicate Staphylococcus aureus colonization in critically ill infants; results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Infection

Drugs mentioned

• Mupirocin (Mupirocin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Staphylococcal Infection | Phase 2 | Status: COMPLETED | Results posted: 2017-07-07